Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
14 Febbraio 2025 - 7:09PM
Edgar (US Regulatory)
Exhibit 1
Joint Filing Agreement
The undersigned agree that this Schedule 13G, and all amendments
thereto, relating to the common stock of Nevro Corp. shall be filed on behalf of the undersigned.
SHAY CAPITAL LLC
By: Shay Capital Holdings LLC, its Manager
By: /s/ Elan Foxman
Name: Elan Foxman
Title: Chief Financial Officer
SHAY CAPITAL HOLDINGS LLC
By: /s/ Elan Foxman
Name: Elan Foxman
Title: Chief Financial Officer
Dated: February 14, 2025
Exhibit 2
Due to the relationships
between them, the reporting persons hereunder may be deemed to constitute a “group” with one another for purposes of Section
13(d)(3) of the Securities Exchange Act of 1934.
Grafico Azioni Nevro (NYSE:NVRO)
Storico
Da Feb 2025 a Mar 2025
Grafico Azioni Nevro (NYSE:NVRO)
Storico
Da Mar 2024 a Mar 2025